Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Money

Theranos founder faces court on fraud charges

Published

on

The trial into the now-defunct blood testing startup Theranos has begun, with founder Elizabeth Holmes facing several charges of criminal fraud.

Prosecutors alleged Holmes “lied and cheated” for money and fame during the first day of one of the most closely watched trials of a U.S corporate executive in years.

The former Silicon Valley star is accused of deceiving investors and patients, by claiming Theranos technology could detect common illnesses using just a few drops of blood from a finger prick.

The company collapsed in 2015 after it emerged the blood-testing devices did not work, and had instead been operating commercially available machines made by other manufacturers.

“Significant problems brewing”

Prosecutors claimed that Holmes and other executives turned to fraud in 2009 after big pharmaceutical firms refused to back Theranos and the company faced bankruptcy.

Holmes lied about tests and exaggerated the company’s performance to secure millions of dollars of investments between 2010 to 2015.

This included false claims that the tests had been processed by pharmaceutical giant Pfizer, and that the technology was being used in the field by the U.S military.

Defence tells court Holmes is “no villain”

At the centre of Holmes’ defence is the argument she never intended to commit fraud.

Instead, they argue, Theranos is a high-profile example of a startup that simply did not work, much like thousands of other failed business ideas.

They told jurors that Holmes is not a villain, but rather a hard-working, young and naive businesswoman, who poured much of her life into the company.

“Failure is not a crime. Trying your hardest and coming up short is not a crime,” defence attorney Lance Wade said.

“In the end, Theranos failed and Ms Holmes walked away with nothing,” he told the jury.

Former executive and romantic partner also charged

Ex-Theranos executive Ramesh Balwani – who was romantically involved with Holmes for years, faces the same charges, but will be tried separately.

He has pleaded not guilty.

According to court documents released to the public, Holmes has accused Balwani of years of emotional and psychological abuse – allegations which Balwani denies.

Holmes’ lawyers have indicated she is highly likely to take the witness stand and testify about the effect her relationship with Balwani had on her mental state.

Court case the culmination of ill-fated saga

Holmes’ story is one which has peaked public interest.

After founding Theranos in 2003, aged 19, Holmes was fast-tracked for Silicon Valley success – she was at one point dubbed the world’s youngest self-made female billionaire and the “next Steve Jobs”.

Theranos “dazzled” large firms such as Walgreens and pharmacy companies into agreeing testing partnerships, as well as securing investments from high-profile figures like media mogul Rupert Murdoch and former U.S secretary of state Henry Kissinger.

Her story has become the subject of documentaries, podcasts and books. A TV miniseries and a film based on her life are in the works.

A tumultuous story will now culminate in a decision made in a California courtroom, with the case expected to last months.

If guilty, Holmes faces up to 20 years in prison.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Money

Stocks rally ahead of Thanksgiving as markets log four days of gains

Markets gain momentum ahead of Thanksgiving, with the Dow up 388 points and Oracle rising 4% amid investor optimism.

Published

on

Markets gain momentum ahead of Thanksgiving, with the Dow up 388 points and Oracle rising 4% amid investor optimism.


Markets are moving into the Thanksgiving break with strong momentum, as stocks notch four straight days of gains. The Dow Jones Industrial Average jumped 388 points, while the S&P 500 added 0.9%, pushing both indexes toward their best week since June.

Oracle led major movers, rising more than 4% after Deutsche Bank reaffirmed its bullish outlook on the tech giant. Broad investor optimism continues building across sectors as economic data softens and earnings remain resilient.

All eyes are now on the Federal Reserve and what potential shifts in interest-rate policy may mean for the markets. U.S. markets will close Thursday for the Thanksgiving holiday and reopen Friday for a shortened trading session.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker

#Markets #Stocks #Thanksgiving #DowJones #SP500 #Oracle #FederalReserve #FinanceNews


Download the Ticker app

Continue Reading

Money

Dow surges 500 points amid rate cut optimism

Dow jumps 569 points on fresh hopes for December rate cut and AI market optimism

Published

on

Dow jumps 569 points on fresh hopes for December rate cut and AI market optimism

video
play-sharp-fill
In Short:
– Dow Jones rose 569 points, reflecting optimism for a Federal Reserve interest rate cut.
– Alphabet’s stock increased as Meta may invest in AI chips, but Nvidia’s declined amid market concerns.
The Dow Jones Industrial Average increased by 569 points or 1.2% on Tuesday, reflecting investor optimism for an upcoming Federal Reserve interest rate cut. The S&P 500 and Nasdaq Composite also posted gains, up 0.8% and 0.4% respectively. This represented a recovery from earlier losses, where the S&P 500 briefly fell by 0.7%.Banner

Markets anticipate an 85% chance of a quarter-point rate cut in December, driven by comments from New York Fed President John Williams, who indicated the possibility of lower rates soon. Investor sentiment strengthened following reports that Kevin Hassett may be appointed as the next Fed chair, potentially resulting in a more lenient monetary policy.

Tech Sector

Alphabet saw its stock rise by over 1% after reports indicated that Meta Platforms might invest in its AI chips. This could signal increased demand for AI technology, benefiting the sector overall. However, Nvidia’s stock fell more than 3%, suggesting concerns about its dominance in the AI chip market.

Investors are also wary of the valuation of tech stocks. Despite recent gains, the S&P 500 and Nasdaq remain down over 1% and 3%, respectively, for November, while the Dow has lost more than 1% this month. The broader market’s performance indicates ongoing scrutiny regarding tech valuations amid changing economic expectations.


Download the Ticker app

Continue Reading

Money

Gold prices surge as Central Banks buy big, but risks grow ahead

Gold prices surge as central banks increase demand; risks include a stronger dollar and rising interest rates.

Published

on

Gold prices surge as central banks increase demand; risks include a stronger dollar and rising interest rates.


Gold prices are climbing fast as central banks ramp up buying, pushing demand to its highest levels in years. The metal’s reputation as a safe haven is strengthening, especially amid rising geopolitical tensions and global financial uncertainty.

But experts warn the shine could fade. A stronger US dollar and the possibility of rising interest rates may weigh on momentum, making investors question how long the rally can last.

Dr Steven Enticott from CIA Tax breaks down the drivers behind gold’s surge—from ETF inflows to physical bar demand—and what could send the price sharply higher… or lower.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker

#gold #markets #centralbanks #economy #finance #investing #interestRates #usdollar


Download the Ticker app

Continue Reading

Trending Now